Today more than 71 % of children with cancer are surviving their disease. This is because of improved treatment including aggressive combination therapy and better supportive care measures. The majority of patients with bone tumors are now being treated with surgery, chemotherapy, and radiation therapy, resulting in an increase in numbers of long-term survivors. This aggressive therapy, however, has increased the risk of developing late effects. This article reviews some of these late effects in survivors of bone tumors diagnosed in childhood or adolescence. Areas that are explored include cardiac, infections, second operations, second malignant neoplasms, renal, auditory, fertility, pulmonary, functional, and psychosocial outcomes. The need for long-term follow-up clinics is also addressed.
Get full access to this article
View all access options for this article.
References
1.
American Cancer Society: Cancer facts and figures. Atlanta, GA, American Cancer Society, 1997
2.
Greenberg DB , Goorin A., Gebhardt MC, et al: Quality of life. in osteosarcoma survivors . Oncology8:19-25, 1994
3.
Grier H, Krailo M, Tarbell N, et al: Adding ifosfamide and etoposide to vincristine, cyclophosphamide, Adriamycin and Actinomycin improves outcome in non
Nicholson HS : Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma. Med Pediatr Oncol20:6-12, 1992
6.
Malawar MM: Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg76[Am]:1154-1165, 1995
7.
Rougraff BT, Simon MA, Kneisle JS, et al: Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg76[Am]: 649-656, 1994
8.
Tebbi CK: Adjustment to amputation among adolescent oncology patients. Am J Pediatr Hematol Oncol11:275-280,1989
9.
Tebbi CK: Psychological effects of amputation in osteosarcoma, in Humphrey GB (ed): Osteosarcoma in Adolescents and Young Adults. Boston, MA,Kluwer Academic Publisher, 1993, pp 30-44
10.
Nicholson HS, Mulvihill J.: Late effects of therapy in survivors of childhood and adolescent osteosarcoma , in Humphrey GB (ed): Osteosarcoma in Adolescents and Young Adults, Boston, MA,Kluwer Academic Publisher, 1993 , pp 45-48
11.
Meistrich ML , Chawla SP, Da Cunha MF, et al: Recovery of sperm production after chemotherapy for osteosarcoma. Cancer63:2115-2123, 1989
12.
Truesdell S. , Schwartz C., Clark E., et al: Cardiovascular effects of cancer, in Schwartz WL, Hobbie LS, Constine L, et al (eds): Survivors of Childhood Cancer: Assessment and Management. St Louis, MO, Mosby, 1994, pp 159-175
13.
Lipshultz S. , Colan S., Geiber R., et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood . N Engl J Med324:808-815, 1992
14.
Postma A., Bink-Boelkens Mte, Beaufort-Krol Gcm, et al: Late cardiotoxicity after treatment for a malignant bone tumor . Med Pediatr Oncol26:230-237, 1996 14. Steinherz L., Steinherz P., Tan C., et al: Cardiac toxicity 4 to 20 years after completing anthracycline therapy . JAMA266:1672-1677, 1991
15.
DeLaat C.: Long-term survivors of childhood cancer: Evaluation and identification of sequelae of treatment. CA Cancer J Clin42:263-282, 1992
16.
Steinherz L, Graham T, Hurwitz R, et al: Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the cardiology commit
17.
tee of the Children's Cancer Study Group. Pediatrics89:942-949, 1992
18.
Martin G., Seibel N., Majd M.: Real-time automated echocardiographic measures of ventricular area and area change: Comparison of radionuclide technique. Echo11:111-117, 1994
19.
Dealy MF: Care of the adolescent undergoing an allograft procedure. Cancer Nurs18:130-137, 1995
20.
Marcus RB, McGrath B., O'Conner K., et al: Long-term effects on the musculoskeletal and integumentary systems and the breast, in Schwartz CL, Hobbie WL, Constine LS, et al (eds): Survivors of Childhood Cancer: Assessment and Management . New York, NY, Mosby, 1994, pp 263-292
21.
Meadows A., Fenton J.: Follow-up care of patients at risk for the development of second malignant neoplasms, in Schwartz WL, Hobbie LS, Constine L, et al (eds): Survivors of Childhood Cancer: Assessment and Management . St Louis, MO, Mosby, 1994, pp 319-328
22.
Tucker MA: Bone sarcomas linked to radiotherapy and chemotherapy in children . N Engl J Med317:588-593,1987
23.
Meadows AT: Second malignant neoplasms in childhood cancer survivors. J Assoc Pediatr Oncol Nurses 6:1, 1989
24.
Kuttesch J. , Wexler L., Marcus R., et al: Second malignancies after Ewings sarcoma: Radiation dose-dependency of secondary sarcoma. J Clin Oncol14: 2818-2825,1996
25.
Green DM, Zevon MA, Reese PA, et al: Second malignant tumors following treatment during childhood and adolescence for cancer. Med Pediatr Oncol22:1-10, 1993
26.
Ozaki T.: Second malignant neoplasms after treatment for osteosarcoma. Acta Med Okayama47:129-133, 1993
27.
Hawkins MM, Kinnier Wilson LM, Burton HS, et al: Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Nat Cancer Inst88:5270-5277, 1996
28.
Raney B., Heyn R., Cassady R., et al: Late effects of cancer therapy on the genitourinary tract in children, in Schwartz WL, Hobbie LS, Constine L, et al (eds): Survivors of Childhood Cancer: Assessment and Management . St Louis, MO, Mosby, 1994, pp 245-262
29.
McKeage M.: Comparative adverse effect profiles of platinum drugs. Drug Safety13:228-244, 1995
30.
Pratt C., Meyer W., Jenkins J., et al: Ifosfamide, Fanconi's syndrome, and rickets. J Clin Oncol9:1495-1499, 1991
31.
Rossi R., Godde A., Kleinebrand A., et al: Concentrating capacity in ifosfamide-induced severe renal dysfunction . Renal Failure17:551-557, 1995
32.
Donahue B., Meyerowitz C., Handler S., et al: Head and neck, in Schwartz C , Hobbie W, Constine L, et al (ed): Survivors of Childhood Cancer. St Louis, MO, Mosby, 1994, pp 144-146
33.
McHaney J., Kovnar E., Meyer W., et al: Effects of radiation therapy and chemotherapy on hearing, in Green DM, D'Angio GJ (eds): Late Effects of Treatment for Childhood Cancer . New York, NY, Wiley-Liss, 1992, pp7-10
34.
Leventhal BG , Halperin EC, Torano AE: The testes, In Schwartz, CL, Hobbie WL, Constine L, et al (ed): Survivors of Childhood Cancer: Assessment and Management . St Louis, MO, Mosby, 1994, pp 225-244
35.
Marshall WA , Tanner JM: Variation in pattern of pubertal changes in boys. Arch Dis Child45:13-23, 1970
36.
Barton C., Waxman J.: Effects of chemotherapy on fertility. Blood Rev4:187-195, 1990
37.
Aubier F., Flamant F., Brauner R., et al: Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol7:304-309, 1989
38.
Neequaye JE , Byrne J., Levine PH: Menarche and reproduction after treatment for African Burkitt's lymphoma. Br Med J303:1033, 1991
39.
Torano AE, Halperin EC, Leventhal BG: The ovary. In Schwartz CL, Hobbie WL, Constine L, et al (eds): Survivors of Childhood Cancer: Assessment and Management . St Louis, MO, Mosby, 1994, pp 213-224.
40.
Byrne J.: Fertility and pregnancy after malignancy. Semin Perinatol14:423-429, 1990
41.
Nicholson HS , Byrne J.: Fertility and pregnancy after treatment for cancer during childhood or adolescence. Cancer71:3392-3399, 1993
42.
Kaye R., Oski FA, Barness LA: Core Textbook of Pediatrics. Philadelphia, PALippincott, 1988; pp 188 (as adapted from Marshall WA, Tanner JM: Archives Dis Childhood1969; and Marshall WA, Tanner JM: Archives Dis Childhood1970; pp 45:13
43.
McDonald S., Rubin P., Schwartz CL: Pulmonary effects of antineoplastic therapy, in Schwartz WL, Hobbie LS, Constine L, et al (eds): Survivors of Childhood Cancer: Assessment and Management. St Louis, MO, Mosby, 1994, pp 177-195
44.
Kharasch VS, Lipsitz S., Santis W., et al: Long-term pulmonary toxicity of multiagent chemotherapy includ
45.
ing bleomycin and cyclophosphamide in osteosarcoma survivors. Med Pediatr Oncol27:85-91, 1996
Ellis E., Marcus R., Cicale M., et al: Pulmonary function tests after whole-lung irradiation and doxorubicin in patients with osteogenic sarcoma. J Clin Oncol10:459-463, 1992
48.
Tebbi CK, Mallon JC: Long-term psychosocial outcome among cancer amputees in adolescence and early adulthood. J Psychosoc Oncol5:69-82,
49.
Tebbi CK: Long-term vocational adjustment of cancer patients diagnosed during adolescence . Cancer63:213-218, 1989
50.
Hoffman B.: Legal issues, in Schwartz CL, Hobbie WL, Constine LS, et al (eds): Survivors of Childhood Cancer: Assessment and Management . St Louis, MO, Mosby, 1994, pp 339-356
51.
Byrne J., Fears TR, Steinhorn SC, et al: Marriage and divorce after childhood and adolescent cancer. JAMA262:2693-2699, 1989
52.
Hays DM, Landverk J., Sallan SE, et al: Educa. tional, occupational, and insurance status of childhood cancer survivors in their fourth and fifth decades of life. J Clin Oncol10:1397-1406, 1992
53.
Passik SD: The Greenberg et al article reviewed. Oncology8:25-26, 1994
54.
Strouse TB: The Greenberg et al article reviewed. Oncology8:32-35, 1994
55.
Stuber M., Nader K., Yasuda P., et al: Stress responses after pediatric bone marrow transplantation: Preliminary results of a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry30:952-957, 1991
56.
Ruccione KS: Issues in survivorship, in Schwartz CL, Hobbie WL, Constine LS, et al (eds): Survivors of Childhood Cancer: Assessment and Management . New York, NY, Mosby, 1994, pp 333-334
